Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says
NCI, Dialogue Plan A National Tissue Bank
Group Chairmen Criticize NCI Budget Priorities
Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials
Kimes, Lenfant, To Retire
Cancer.gov Knocked Offline By Theft Of Routers
Six Centers Win Grants
PHS Plans Revitalization of Commissioned Corps
Funding Opportunities Listed (12-page issue).
Trending Stories
- As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - mRNA vaccine for melanoma is hailed as a turning point in medicine
The data from Moderna and Merck’s trial have yet to be presented
